oxcarbazepine

Product NDC
33342-259
11-digit product format
333420259
Labeler code
33342
Product ID
33342-259_962098cc-2d84-4723-a296-b110f1fd659e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
oxcarbazepine
Dosage form
FOR SUSPENSION
Route
ORAL
Labeler
Macleods Pharmaceuticals Limited
Application
ANDA207300
Marketing category
ANDA
Marketing start
2025-07-11
Substance
OXCARBAZEPINE
Active strength
300 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A207300-001OXCARBAZEPINEOXCARBAZEPINE300MG/5MLSUSPENSION / ORALAB2025-07-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A207300-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A207300-001OXCARBAZEPINE300MG/5MLSUSPENSION / ORALAB2025-07-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207300-001OXCARBAZEPINE300MG/5MLSUSPENSION / ORALAB2025-07-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A207300-001OXCARBAZEPINE300MG/5MLSUSPENSION / ORALAB2025-07-116a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A207300-001OXCARBAZEPINE300MG/5MLSUSPENSION / ORALAB2025-07-11a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A207300-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207300-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A207300-001AB16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A207300-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
oxcarbazepine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OXCARBAZEPINE300 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
VZI5B1W380Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
283536Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
962098cc-2d84-4723-a296-b110f1fd659eAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ca2a6da1-5711-44d0-9e79-c84d4265f98bProduct name320250724
536d5b6b-66f1-478b-2670-88fd15947e3bProduct name720250218
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
33342-259-67oxcarbazepine250 mL in 1 BOTTLEFOR SUSPENSION2501
33342-259-67oxcarbazepine1 in 1 CARTONFOR SUSPENSION11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
oxcarbazepineOXCARBAZEPINEMacleods Pharmaceuticals Limited962098cc-2d84-4723-a296-b110f1fd659e2025-08-29Warnings, Adverse reactionsExact identifier
application applno (ANDA): 207300
application number: ANDA207300
ndc (product): 33342-259

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
283536oxacarbazepine 300 MG in 5 mL Oral SuspensionPSN962098cc-2d84-4723-a296-b110f1fd659e1
283536oxcarbazepine 60 MG/ML Oral SuspensionSCD962098cc-2d84-4723-a296-b110f1fd659e1
283536oxacarbazepine 300 MG per 5 ML Oral SuspensionSY962098cc-2d84-4723-a296-b110f1fd659e1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
33342-259-67333420259671 BOTTLE in 1 CARTON (33342-259-67) / 250 mL in 1 BOTTLE1 bottle2025-07-11NoNoCurrent